Potential of Stem Cell-Based Therapy for Ischemic Stroke

Overview

Journal Front Neurol

Specialty Neurology

Date 2018 Feb 23

PMID 29467713

Citations 62

Authors

Hany E Marei

A Hasan

R Rizzi

A Althani

N Afifi

C Cenciarelli

Thomas Caceci

Ashfaq Shuaib

Affiliations

Soon will be listed here.

Abstract

Ischemic stroke is one of the major health problems worldwide. The only FDA approved anti-thrombotic drug for acute ischemic stroke is the tissue plasminogen activator. Several studies have been devoted to assessing the therapeutic potential of different types of stem cells such as neural stem cells (NSCs), mesenchymal stem cells, embryonic stem cells, and human induced pluripotent stem cell-derived NSCs as treatments for ischemic stroke. The results of these studies are intriguing but many of them have presented conflicting results. Additionally, the mechanism(s) by which engrafted stem/progenitor cells exert their actions are to a large extent unknown. In this review, we will provide a synopsis of different preclinical and clinical studies related to the use of stem cell-based stroke therapy, and explore possible beneficial/detrimental outcomes associated with the use of different types of stem cells. Due to limited/short time window implemented in most of the recorded clinical trials about the use of stem cells as potential therapeutic intervention for stroke, further clinical trials evaluating the efficacy of the intervention in a longer time window after cellular engraftments are still needed.

Citing Articles

Exosomes derived from highly scalable and regenerative human progenitor cells promote functional improvement in a rat model of ischemic stroke.

Lee J, Var S, Chen D, Natera-Rodriguez D, Hassanipour M, West M bioRxiv. 2025; .

PMID: 39829810 PMC: 11741374. DOI: 10.1101/2025.01.07.631793.

Real-Time, Non-Invasive Monitoring of Neuronal Differentiation Using Intein-Enabled Fluorescence Signal Translocation in Genetically Encoded Stem Cell-Based Biosensors.

Lee E, Choi H, Kwon Y, Lee K Adv Funct Mater. 2024; 34(29).

PMID: 39308638 PMC: 11412434. DOI: 10.1002/adfm.202400394.

Emerging Roles of Exosomes in Stroke Therapy.

Larson A, Natera-Rodriguez D, Crane A, Larocca D, Low W, Grande A Int J Mol Sci. 2024; 25(12).

PMID: 38928214 PMC: 11203879. DOI: 10.3390/ijms25126507.

Stem cell therapy as a promising approach for ischemic stroke treatment.

Yaqubi S, Karimian M Curr Res Pharmacol Drug Discov. 2024; 6:100183.

PMID: 38831867 PMC: 11144755. DOI: 10.1016/j.crphar.2024.100183.

Human-Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Showed Neuronal Differentiation, Neurite Extension, and Formation of Synaptic Structures in Rodent Ischemic Stroke Brains.

Kanemura Y, Yamamoto A, Katsuma A, Fukusumi H, Shofuda T, Kanematsu D Cells. 2024; 13(8.

PMID: 38667286 PMC: 11048851. DOI: 10.3390/cells13080671.

References

Honmou O . [Phase III clinical trial using autologous mesenchymal stem cells for stroke patients]. Nihon Rinsho. 2016; 74(4):649-54. View

Mine Y, Tatarishvili J, Oki K, Monni E, Kokaia Z, Lindvall O . Grafted human neural stem cells enhance several steps of endogenous neurogenesis and improve behavioral recovery after middle cerebral artery occlusion in rats. Neurobiol Dis. 2013; 52:191-203. DOI: 10.1016/j.nbd.2012.12.006. View

Smith E, Stroemer R, Gorenkova N, Nakajima M, Crum W, Tang E . Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke. Stem Cells. 2012; 30(4):785-96. DOI: 10.1002/stem.1024. View

Moniche F, Rosado-de-Castro P, Escudero I, Zapata E, de la Torre Laviana F, Mendez-Otero R . Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials. Stem Cells Int. 2016; 2016:8657173. PMC: 4972913. DOI: 10.1155/2016/8657173. View

Zhang Z, Chopp M . Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol. 2009; 8(5):491-500. PMC: 2727708. DOI: 10.1016/S1474-4422(09)70061-4. View

Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K . Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol. 2009; 27(8):743-5. DOI: 10.1038/nbt.1554. View

Schoenhals M, Kassambara A, De Vos J, Hose D, Moreaux J, Klein B . Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun. 2009; 383(2):157-62. DOI: 10.1016/j.bbrc.2009.02.156. View

Wichterle H, Lieberam I, Porter J, Jessell T . Directed differentiation of embryonic stem cells into motor neurons. Cell. 2002; 110(3):385-97. DOI: 10.1016/s0092-8674(02)00835-8. View

Darsalia V, Kallur T, Kokaia Z . Survival, migration and neuronal differentiation of human fetal striatal and cortical neural stem cells grafted in stroke-damaged rat striatum. Eur J Neurosci. 2007; 26(3):605-14. DOI: 10.1111/j.1460-9568.2007.05702.x. View

10.

Chen L, Zhang G, Khan A, Guo X, Gu Y . Clinical Efficacy and Meta-Analysis of Stem Cell Therapies for Patients with Brain Ischemia. Stem Cells Int. 2016; 2016:6129579. PMC: 5021879. DOI: 10.1155/2016/6129579. View

11.

Zents K, Copray S . The Therapeutic Potential of Induced Pluripotent Stem Cells After Stroke: Evidence from Rodent Models. Curr Stem Cell Res Ther. 2015; 11(2):166-74. DOI: 10.2174/1574888x10666150728121324. View

12.

Choo A, Tan H, Ang S, Fong W, Chin A, Lo J . Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells. 2008; 26(6):1454-63. DOI: 10.1634/stemcells.2007-0576. View

13.

Battistella V, de Freitas G, Barbosa da Fonseca L, Mercante D, Gutfilen B, Goldenberg R . Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med. 2010; 6(1):45-52. DOI: 10.2217/rme.10.97. View

14.

Buhnemann C, Scholz A, Bernreuther C, Malik C, Braun H, Schachner M . Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats. Brain. 2006; 129(Pt 12):3238-48. DOI: 10.1093/brain/awl261. View

15.

Fu W, Wang S, Zhou G, Liu W, Cao Y, Zhang W . Residual undifferentiated cells during differentiation of induced pluripotent stem cells in vitro and in vivo. Stem Cells Dev. 2011; 21(4):521-9. DOI: 10.1089/scd.2011.0131. View

16.

Hess D, Wechsler L, Clark W, Savitz S, Ford G, Chiu D . Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2017; 16(5):360-368. DOI: 10.1016/S1474-4422(17)30046-7. View

17.

Baker E, Platt S, Lau V, Grace H, Holmes S, Wang L . Induced Pluripotent Stem Cell-Derived Neural Stem Cell Therapy Enhances Recovery in an Ischemic Stroke Pig Model. Sci Rep. 2017; 7(1):10075. PMC: 5577218. DOI: 10.1038/s41598-017-10406-x. View

18.

Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

19.

Ito D, Okano H, Suzuki N . Accelerating progress in induced pluripotent stem cell research for neurological diseases. Ann Neurol. 2012; 72(2):167-74. DOI: 10.1002/ana.23596. View

20.

De Feo D, Merlini A, Laterza C, Martino G . Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection. Curr Opin Neurol. 2012; 25(3):322-33. DOI: 10.1097/WCO.0b013e328352ec45. View